ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01615796
Recruitment Status : Completed
First Posted : June 11, 2012
Last Update Posted : May 9, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 21, 2014
  Actual Study Completion Date : February 21, 2014